Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?
Shannon HK Kim, David Habashy, Sana Pathan, Vincent Tse, Ruth Collins, Lewis Chan
Int Neurourol J. 2016;20(1):40-46.   Published online 2016 Mar 16
DOI: https://doi.org/10.5213/inj.1630450.225
Citations to this article as recorded by
  Crossref logo
Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder—Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes
Yin-Chien Ou, Yao-Lin Kao, Yi-Hui Ho, Kuan-Yu Wu, Hann-Chorng Kuo
Toxins.2023; 15(2): 95.     CrossRef
Bladder Dysfunction in Older Adults: The Botulinum Toxin Option
Yao-Lin Kao, Yin-Chien Ou, Hann-Chorng Kuo
Drugs & Aging.2022; 39(6): 401.     CrossRef
Effect of mesenchymal stem cells on induced skeletal muscle chemodenervation atrophy in adult male albino rats
Azza S. Shehata, Nabila M. Al-Ghonemy, Samah M. Ahmed, Samar R. Mohamed
The International Journal of Biochemistry & Cell Biology.2017; 85: 135.     CrossRef